ROSSIN; Raffaella

Patent Applications and Registrations

Patent applications and USPTO patent grants for ROSSIN; Raffaella.The latest application filed is for "compounds comprising a linker for increasing transcyclooctene stability".

Company Profile

0.14.22

ROSSIN; Raffaella - Eindhover NL
ROSSIN; Raffaella - Eindhoven NL
Rossin; Raffaella - St. Louis MO

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds Comprising A Linker For Increasing Transcyclooctene Stability App 20210308207 - ROBILLARD; Marc Stefan ; et al.	2021-10-07
Tetrazines For High Click Conjugation Yield In Vivo And High Click Release Yield App 20210299286 - ROBILLARD; Marc Stefan ; et al.	2021-09-30
Bio-orthogonal Drug Activation App 20210162060 - ROBILLARD; Marc Stefan ; et al.	2021-06-03
Bio-orthogonal drug activation Grant 10,967,069 - Robillard , et al. April 6, 2	2021-04-06
Chemically cleavable group Grant 10,927,139 - Robillard , et al. February 23, 2	2021-02-23
Chemically Cleavable Group App 20210002320 - ROBILLARD; Marc Stefan ; et al.	2021-01-07
Bio-orthogonal Drug Activation App 20190336612 - ROBILLARD; Marc Stefan ; et al.	2019-11-07
Cleavable Tetrazine Used In Bio-orthogonal Drug Activation App 20190247513 - ROBILLARD; Marc Stefan ; et al.	2019-08-15
Bio-orthogonal drug activation Grant 10,376,594 - Robillard , et al. A	2019-08-13
Bio-orthogonal drug activation Grant 9,931,408 - Robillard , et al. April 3, 2	2018-04-03
Pretargeting kit for imaging or therapy comprising a trans-cyclooctene dienophile and a diene Grant 9,913,921 - Robillard , et al. March 13, 2	2018-03-13
Pretargeting kit, method and agents used therein Grant 9,463,256 - Lub , et al. October 11, 2	2016-10-11
Agents for clearing biomolecules from circulation Grant 9,427,482 - Rossin , et al. August 30, 2	2016-08-30
Bio-orthogonal Drug Activation App 20160151505 - Robillard; Marc Stefan ; et al.	2016-06-02
Bio-orthogonal Drug Activation App 20160106859 - ROBILLARD; MARC STEFAN ; et al.	2016-04-21
Chemically Cleavable Group App 20150344514 - Robillard; Marc Stefan ; et al.	2015-12-03
Cell permeable nanoconjugates of shell-crosslinked knedel (SCK) and peptide nucleic acids ("PNAs") with uniquely expressed or over-expressed mRNA targeting sequences for early diagnosis and therapy of cancer Grant 9,095,601 - Becker , et al. August 4, 2	2015-08-04
Pretargeting Kit For Imaging Or Therapy Comprising A Trans-cyclooctene Dienophile And A Diene App 20140093450 - Robillard; Marc Stefan ; et al.	2014-04-03
Bio-orthogonal Drug Activation App 20140093522 - Robillard; Marc Stefan ; et al.	2014-04-03
Agents For Clearing Biomolecules From Circulation App 20130272959 - Rossin; Raffaella ; et al.	2013-10-17
CELL PERMEABLE NANOCONJUGATES OF SHELL-CROSSLINKED KNEDEL (SCK) AND PEPTIDE NUCLEIC ACIDS ("PNAs") WITH UNIQUELY EXPRESSED OR OVER-EXPRESSED mRNA TARGETING SEQUENCES FOR EARLY DIAGNOSIS AND THERAPY OF CANCER App 20130230452 - Becker; Matthew L. ; et al.	2013-09-05
Pretargeting Kit, Method And Agents Used Therein App 20130189184 - Lub; Johan ; et al.	2013-07-25
Cell permeable nanoconjugates of shell-crosslinked knedel (SCK) and peptide nucleic acids ("PNAs") with uniquely expressed or over-expressed mRNA targeting sequences for early diagnosis and therapy of cancer Grant 8,354,093 - Becker , et al. January 15, 2	2013-01-15
Pretargeting Kit, Method And Agents Used Therein App 20120039803 - Robillard; Marc Stefan ; et al.	2012-02-16
Pretargeting Kit, Method And Agents Used Therein App 20120034161 - Robillard; Marc Stefan ; et al.	2012-02-09
Cell permeable nanoconjugates of shell-crosslinked knedel (SCK) and peptide nucleic acids ("PNAs") with uniquely expressed or over-expressed mRNA targeting sequences for early diagnosis and therapy of cancer App 20060159619 - Becker; Matthew L. ; et al.	2006-07-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.